Sophia Frentzas

3PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 06, 2024
A Phase Ib/II Randomized Clinical Trial of Oleclumab with or without Durvalumab plus Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma.

Andrew L Coveler, Matthew J Reilley, Mark Zalupski

|Apr 20, 2024
Phase 1a dose escalation study of ivonescimab (AK112/SMT112), an anti-PD-1/VEGF-A bispecific antibody, in patients with advanced solid tumors.

Sophia Frentzas, Anna Rachelle Austria Mislang, Charlotte Lemech

|Oct 19, 2023
AdvanTIG-105: a phase I dose escalation study of the anti-TIGIT monoclonal antibody ociperlimab in combination with tislelizumab in patients with advanced solid tumors.

Sophia Frentzas, Steven Kao, Rang Gao

Pageof 1

Frequent Collaborators

1 joint publications

Wenjing Wang

1 joint publications

Zhongmin Maxwell Wang

1 joint publications

Andrew L Coveler

1 joint publications

Matthew J Reilley